<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-11-05 - City De&#xAD;vel&#xAD;op&#xAD;ments Gland Pharma</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201105/282505776113374" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>City De&#xAD;vel&#xAD;op&#xAD;ments Gland Pharma</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201105/textview" title="The Straits Times - 2020-11-05"><time>2020-11-05</time></a>
        - <span>BUSINESS</span>
        - <span role="byline"></span>
    </section>

    <p>Prop­erty giant City De­vel­op­ments Lim­ited (CDL) yes­ter­day said it has ap­pointed Deloitte & Touche Fi­nan­cial Ad­vi­sory Ser­vices as its ex­ter­nal fi­nan­cial ad­viser to as­sist in fur­ther eval­u­at­ing and re­view­ing its in­vest­ment in China-based Sin­cere Prop­erty Group.</p>
    <p>This comes after CDL di­rec­tor Kwek Leng Peck re­signed last month, cit­ing dis­agree­ments with the board and man­age­ment on the group’s in­vest­ment in Sin­cere, as well as its man­age­ment of Lon­don-based unit Mil­len­nium & Copthorne Ho­tels.</p>
    <p>CDL’s board noted that it man­dated the eval­u­a­tion by Deloitte in view of the “chal­lenges re­lat­ing to Sin­cere’s liq­uid­ity po­si­tion”.</p>
    <p>Gland Pharma and its share­hold­ers are look­ing to raise as much as 64.5 bil­lion ru­pees (S$1.18 bil­lion) in what would be In­dia’s big­gest ini­tial public of­fer­ing (IPO) by a phar­ma­ceu­ti­cal firm.</p>
    <p>The com­pany and ex­ist­ing share­hold­ers, in­clud­ing Fo­sun Pharma In­dus­trial, are sell­ing as many as 43.2 mil­lion shares in the of­fer­ing, ac­cord­ing to terms of the deal ob­tained by Bloomberg News. The shares are mar­keted at 1,490 ru­pees to 1,500 ru­pees each.</p>
    <p>At S$1.18 bil­lion, Gland Pharma’s IPO would be the largest by a phar­ma­ceu­ti­cal firm in In­dia, way above the S$354.3 mil­lion share sale by Eris Life­sciences in 2017, ac­cord­ing to Bloomberg.</p>

    <div>
        <picture>
            <img src="https://i.prcdn.co/img?regionKey=ctam%2fPQCWzLQer2p8hJ62g%3d%3d" />
        </picture>
        <span role="byline">PHOTO: CDL</span>
        <p data-role="text">City De&#xAD;vel&#xAD;op&#xAD;ments is re&#xAD;view&#xAD;ing its in&#xAD;vest&#xAD;ment in Sin&#xAD;cere Prop&#xAD;erty Group, a key de&#xAD;vel&#xAD;oper in Zhengzhou Fi&#xAD;nan&#xAD;cial Is&#xAD;land (above).</p>
    </div>

</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
